CX3CR1 and congestive heart failure: Furthermore, a significant reduction in circulating levels of the CX3CR1 ligand, fractalkine, has been shown in congestive heart failure in patients treated with Reconstituted HDL (rHDL), a lipoprotein known to have anti-inflammatory properties.15